The fact that? Beiersdorf has announced a strategic investment and a collaboration with Vincere Cinemosciences for the development of innovative skin solutions aimed at cell health and skin aging, focusing on cutting and the process of mythophagy.
The details The association combines the experience of decades of Beiersdorf with Coenzyme Q10, a key antioxidant in mitochondrial health, with the innovative research of Vincere on USP30, an enzyme that regulates the elimination of the damaged mitochondria. Together, companies aim to take advantage of mythophagy, the cellular process that eliminates malfunction mitochondria, to create advanced cosmetic formulations that promote the vitality of the skin and visible signs of visible aging. Vincere, mainly focused on the investigation of neurodegenerative disease, sees this collaboration as an opportunity to extend its UWNDAs channel to the cosmetics and personal care sector, with Beiersdorf applying guapas.
Why? As consumers seek more and more scientifically validated and high -performance anti -aging solutions, Beiersdorf’s movement indicates their ambition to stay at the forefront of cosmetic innovation taking advantage of the advances in biotechnology. The association not only strengthens Beiersdorf’s position as an innovative for skin care, but also unites the worlds of pharmaceutical research and beauty, translating complex cell science into tangible benefits for skin health and rejuvenation. This investment is aligned with the company’s long -term strategy to deepen its understanding of skin biology and offer technologies of active ingredients of the next general.
Fountain: Beiersdorf
